simvastatin has been researched along with Intestinal Perforation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanrath, P; Janssens, U; Liehn, EA; Lütticken, R; Merx, MW; Schrader, J; Weber, C | 1 |
1 other study(ies) available for simvastatin and Intestinal Perforation
Article | Year |
---|---|
HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis.
Topics: Animals; Aorta; Bradykinin; Cardiac Output; Cardiotonic Agents; Cecal Diseases; Cell Adhesion; Cells, Cultured; Coronary Circulation; Dobutamine; Drug Evaluation, Preclinical; Endothelium, Vascular; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Perforation; Leukocytes; Ligation; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Sepsis; Simvastatin; Ultrasonography | 2004 |